Emma17
6 years agoMember
ASCO 2019 - Aromatase inhibitors - Women need better treatments for side effects
The American Society of Clinical Oncology (ASCO) recently concluded its 2019 conference. ASCO's annual conference is the "bees' knees" of oncology conferences and Australian presenters are usually on the programme.
Below is a link to breastcancer.org and their interview with Dr Dawn Hershman, lead of the Breast Cancer Program at Columbia University (New York) regarding her three-year study using text messaging to improve adherence to AIs. It is titled 'ASCO 2019: Women Don't Need Reminders To Take Aromatase Inhibitors, They Need Better Treatments for Side Effects'. Her study involved postmenopausal women only but the key takeaway applies to pre- and post-menopausal women: side effects (SEs) induce women to discontinue taking AIs.
https://www.breastcancer.org/community/podcasts/hormonal-tx-compliance-20190603
The highlights are:
4:00 - discusses the rates of women stopping AIs at 1, 2, & 3 years (based on urinalysis, 30% stopped AI use at year 1, 40% stopped at year 2, 45% had stopped at year 3). Only 10% of women self-reported stopping.
4.48 - discussion starts to evolve to include SEs with 'We learned a lot'...keep listening here, her POV is interesting
5.56 - women want to keep taking AIs but need good interventions to control SEs
7.09 - we need to enhance patient/provider communication so that we can intervene in the case of SEs
7.23 - women cannot keep taking their AIs because of SEs
8.15 - what are the next steps for research? keep listening here
8.59 - we don't have great treatments for SEs
9.14 - the interviewer revealed she talked to a doctor who attended the ASCO conference and admitted she did not take her AI as long as she should have because of the SEs
9.29 - we have to come up with better treatments for SEs
It is refreshing to hear a cancer specialist at a US Ivy League cancer centre acknowledge the role of SEs in adherence to AI use and that better treatments are required. Too often we are dismissed by healthcare providers with a 'suck it up, sister' attitude.
Currently you can listen directly from the breastcancer.org website or download to your device. The full transcript is '...coming soon...' so bookmark the link and keep checking for it.
Below is a link to breastcancer.org and their interview with Dr Dawn Hershman, lead of the Breast Cancer Program at Columbia University (New York) regarding her three-year study using text messaging to improve adherence to AIs. It is titled 'ASCO 2019: Women Don't Need Reminders To Take Aromatase Inhibitors, They Need Better Treatments for Side Effects'. Her study involved postmenopausal women only but the key takeaway applies to pre- and post-menopausal women: side effects (SEs) induce women to discontinue taking AIs.
https://www.breastcancer.org/community/podcasts/hormonal-tx-compliance-20190603
The highlights are:
4:00 - discusses the rates of women stopping AIs at 1, 2, & 3 years (based on urinalysis, 30% stopped AI use at year 1, 40% stopped at year 2, 45% had stopped at year 3). Only 10% of women self-reported stopping.
4.48 - discussion starts to evolve to include SEs with 'We learned a lot'...keep listening here, her POV is interesting
5.56 - women want to keep taking AIs but need good interventions to control SEs
7.09 - we need to enhance patient/provider communication so that we can intervene in the case of SEs
7.23 - women cannot keep taking their AIs because of SEs
8.15 - what are the next steps for research? keep listening here
8.59 - we don't have great treatments for SEs
9.14 - the interviewer revealed she talked to a doctor who attended the ASCO conference and admitted she did not take her AI as long as she should have because of the SEs
9.29 - we have to come up with better treatments for SEs
It is refreshing to hear a cancer specialist at a US Ivy League cancer centre acknowledge the role of SEs in adherence to AI use and that better treatments are required. Too often we are dismissed by healthcare providers with a 'suck it up, sister' attitude.
Currently you can listen directly from the breastcancer.org website or download to your device. The full transcript is '...coming soon...' so bookmark the link and keep checking for it.